Delivery Order SPE2DB20D2104-SPE2DB24FT59D
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,726.32 Firm Fixed Price Delivery Order is for the supply of 4566528106 - Cetirizine HCl 1 mg/ml solution, 120 ml. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,098.33 contract is for the supply of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.47 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, a generic antihistamine medication. The contract has an ultimate completion date of April 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.74 Firm Fixed Price Delivery Order is for the supply of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,595.73, is for the delivery of Cetirizine HCl 1 mg/ml solution, a prescription medication, to support military and government healthcare programs. The contract has an ultimate completion date of December 7, 2023, and is a firm fixed-price delivery order. This award is part of a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,310.66 Firm Fixed Price delivery order contract is for the supply of Cetirizine HCl 1 mg/ml solution, a generic pharmaceutical product. The award has an ultimate completion date of May 18, 2023 and was made without the use of any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB23FY7RX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,644.50 delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, with a completion date of May 18, 2023. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The award, valued at $7,769.01, is a firm fixed-price delivery order with a completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,197.22 firm-fixed-price delivery order contract is for the supply of Cetirizine HCl 1 mg/ml solution, a generic antihistamine medication, with a completion date of February 2, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.97 firm fixed-price delivery order is for the supply of 4,567,707,523 units of Cetirizine HCL 10 mg tablets, with a performance period through March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT59DDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.99 firm fixed-price delivery order is for the supply of 4564249564 - Cetirizine HCL 1 mg/ml solution, 120 ml. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/11/24 |